Analysis of biological markers of age-related macular degeneration and factors influencing prognosis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024137

Enrollment

Unknown

Registered

2019-06-27

Start date

2019-07-01

Completion date

Unknown

Last updated

2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

age-related macular degeneration

Interventions

Case gorup:Intravitreal injection of anti-VEGF drugs

control group:no invtervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) aged >=45 years; 2) first diagnosed as age-related macular degeneration or polypoid choroidal angiopathy; 3) receive intravitreal injection of anti-vegf drugs (no drug grouping was set).

Exclusion criteria

Exclusion criteria: 1) cataract or corneal opacity; 2) previous treatment with PDT or anti-vegf drugs for other retinal diseases; 3) patients with severe cardiovascular diseases or malignant tumors.

Design outcomes

Primary

Measure	Time frame
visual acuity;	—

Countries

China

Contacts

Public ContactPeirong Lu

The First Affiliated Hospital of Soochow University

lupeirong@suda.edu.cn+86 13914083528

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026